Observational studyClinical drug investigation2024

Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).

Xi Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.